CD4 and systemic lupus erythematosus: So, exploring abnormal expression molecules of CD4+ T lymphocytes in SLE patients may provide reliable targets for the diagnosis, efficacy, and prognosis evaluation of SLE and is also crucial for inhibiting SLE apoptosis and alleviating related cellular dysfunction.